Matrix Approach Assessment of Cabotegravir Drug-Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling.
Saved in:
| Title: | Matrix Approach Assessment of Cabotegravir Drug-Drug Interactions with OAT1/OAT3 Substrates and UGT1A1/UGT1A9 Inhibitors Using Physiologically-Based Pharmacokinetic Modeling. |
|---|---|
| Authors: | Tracey H; GSK, Stevenage SG1 2NY, UK., Bate ST; GSK, Stevenage SG1 2NY, UK., Ford S; GSK, Durham, NC 27701, USA., Patel P; ViiV Healthcare, Durham, NC 27709, USA., Bloomer J; GSK, Stevenage SG1 2NY, UK., Patel A; GSK, Stevenage SG1 2NY, UK., Taskar KS; GSK, Stevenage SG1 2NY, UK. |
| Source: | Pharmaceutics [Pharmaceutics] 2025 Apr 18; Vol. 17 (4). Date of Electronic Publication: 2025 Apr 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1999-4923 |
|---|---|
| DOI: | 10.3390/pharmaceutics17040531 |
